Genomic approaches to DNA repair and mutagenesis

DNA Repair

Volumn 36, Issue , 2015, Pages 146-155

  Wyrick, John J ^a   Roberts, Steven A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Excision repair; Mutagenesis; Mutation signature; Sequencing

Indexed keywords

ANTIBODY; DNA; LESION SPECIFIC ANTIBODY; PROTEIN; REPAIR PROTEIN; RIBONUCLEOTIDE; UNCLASSIFIED DRUG;

BASE PAIRING; CHROMATIN STRUCTURE; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; EXCISION REPAIR; GENE FREQUENCY; GENE MAPPING; GENE MUTATION; GENOMICS; HUMAN; HUMAN GENOME; MODULATION; MUTAGENESIS; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION; CHROMOSOMAL MAPPING; GENETICS; GENOME; METABOLISM;

CHROMOSOME MAPPING; DNA; DNA DAMAGE; DNA REPAIR; GENOME; HUMANS; MUTAGENESIS; SACCHAROMYCES CEREVISIAE;

EID: 84961971182     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2015.09.018     Document Type: Review

References (111)

1. Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 2010, 40:179-204.
2. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., Ellenberger T. DNA Repair and Mutagenesis 2006, ASM Press, Washington, D.C. 2nd ed.
3. Kobayashi N., Katsumi S., Imoto K., Nakagawa A., Miyagawa S., Furumura M., Mori T. Quantitation and visualization of ultraviolet-induced DNA damage using specific antibodies: application to pigment cell biology. Pigment Cell Res. 2001, 14:94-102.
4. Strickland P.T., Boyle J.M. Characterisation of two monoclonal antibodies specific for dimerised and non-dimerised adjacent thymidines in single stranded DNA. Photochem. Photobiol. 1981, 34:595-601.
5. Roza L., van der Wulp K.J., MacFarlane S.J., Lohman P.H., Baan R.A. Detection of cyclobutane thymine dimers in DNA of human cells with monoclonal antibodies raised against a thymine dimer-containing tetranucleotide. Photochem. Photobiol. 1988, 48:627-633.
6. Mizuno T., Matsunaga T., Ihara M., Nikaido O. Establishment of a monoclonal antibody recognizing cyclobutane-type thymine dimers in DNA: a comparative study with 64M-1 antibody specific for (6-4) photoproducts. Mutat. Res. 1991, 254:175-184.
7. Mori T., Nakane M., Hattori T., Matsunaga T., Ihara M., Nikaido O. Simultaneous establishment of monoclonal antibodies specific for either cyclobutane pyrimidine dimer or (6-4) photoproduct from the same mouse immunized with ultraviolet-irradiated DNA. Photochem. Photobiol. 1991, 54:225-232.
8. Mori T., Matsunaga T., Hirose T., Nikaido O. Establishment of a monoclonal antibody recognizing ultraviolet light-induced (6-4) photoproducts. Mutat. Res. 1988, 194:263-270.
9. Matsunaga T., Mori T., Nikaido O. Base sequence specificity of a monoclonal antibody binding to (6-4) photoproducts. Mutat. Res. 1990, 235:187-194.
10. Matsunaga T., Hatakeyama Y., Ohta M., Mori T., Nikaido O. Establishment and characterization of a monoclonal antibody recognizing the Dewar isomers of (6-4) photoproducts. Photochem. Photobiol. 1993, 57:934-940.
11. Bespalov I.A., Bond J.P., Purmal A.A., Wallace S.S., Melamede R.J. Fabs specific for 8-oxoguanine: control of DNA binding. J. Mol. Biol. 1999, 293:1085-1095.
12. Soultanakis R.P., Melamede R.J., Bespalov I.A., Wallace S.S., Beckman K.B., Ames B.N., Taatjes D.J., Janssen-Heininger Y.M. Fluorescence detection of 8-oxoguanine in nuclear and mitochondrial DNA of cultured cells using a recombinant Fab and confocal scanning laser microscopy. Free Radic. Biol. Med. 2000, 28:987-998.
13. Leadon S.A., Hanawalt P.C. Monoclonal antibody to DNA containing thymine glycol. Mutat. Res. 1983, 112:191-200.
14. Chen B.X., Hubbard K., Ide H., Wallace S.S., Erlanger B.F. Characterization of a monoclonal antibody to thymidine glycol monophosphate. Radiat. Res. 1990, 124:131-136.
15. Greferath R., Nehls P. Monoclonal antibodies to thymidine glycol generated by different immunization techniques. Hybridoma 1997, 16:189-193.
16. Le Guern A., Leng M., Kourilsky P. Monoclonal antibodies to DNA modified by the carcinogen N-acetoxy-N-2 acetyl aminofluorene. Dev. Biol. Stand. 1984, 57:409-414.
17. Ball S.S., Quaranta V., Shadravan F., Walford R.L. An ELISA for detection of DNA-bound carcinogen using a monoclonal antibody to N-acetoxy-2-acetylaminofluorene-modified DNA. J. Immunol. Methods 1987, 98:195-200.
18. Iwamoto T.A., Kobayashi N., Imoto K., Yamamoto A., Nakamura Y., Yamauchi Y., Okumura H., Tanaka A., Hanaoka F., Shibutani S., Miyagawa S., Mori T. In situ detection of acetylaminofluorene-DNA adducts in human cells using monoclonal antibodies. DNA Repair 2004, 3:1475-1482.
19. Sundquist W.I., Lippard S.J., Stollar B.D. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II). Proc. Natl. Acad. Sci. U. S. A. 1987, 84:8225-8229.
20. Tilby M.J., Johnson C., Knox R.J., Cordell J., Roberts J.J., Dean C.J. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody. Cancer Res. 1991, 51:123-129.
21. Harbison C.T., Gordon D.B., Lee T.I., Rinaldi N.J., Macisaac K.D., Danford T.W., Hannett N.M., Tagne J.B., Reynolds D.B., Yoo J., Jennings E.G., Zeitlinger J., Pokholok D.K., Kellis M., Rolfe P.A., Takusagawa K.T., Lander E.S., Gifford D.K., Fraenkel E., Young R.A. Transcriptional regulatory code of a eukaryotic genome. Nature 2004, 431:99-104.
22. Hanlon S.E., Lieb J.D. Progress and challenges in profiling the dynamics of chromatin and transcription factor binding with DNA microarrays. Curr. Opin. Genet. Dev. 2004, 14:697-705.
23. Teng Y., Bennett M., Evans K.E., Zhuang-Jackson H., Higgs A., Reed S.H., Waters R. A novel method for the genome-wide high resolution analysis of DNA damage. Nucleic Acids Res. 2011, 39:e10.
24. Zavala A.G., Morris R.T., Wyrick J.J., Smerdon M.J. High-resolution characterization of CPD hotspot formation in human fibroblasts. Nucleic Acids Res. 2014, 42:893-905.
25. Powell J.R., Bennett M.R., Evans K.E., Yu S., Webster R.M., Waters R., Skinner N., Reed S.H. 3D-DIP-Chip: a microarray-based method to measure genomic DNA damage. Sci. Rep. 2015, 5:7975.
26. Deininger P.L., Batzer M.A. Mammalian retroelements. Genome Res. 2002, 12:1455-1465.
27. Suter B., Schnappauf G., Thoma F. Poly(dA.dT) sequences exist as rigid DNA structures in nucleosome-free yeast promoters in vivo. Nucleic Acids Res. 2000, 28:4083-4089.
28. Barbic A., Zimmer D.P., Crothers D.M. Structural origins of adenine-tract bending. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2369-2373.
29. Segal E., Widom J. Poly(dA:dT) tracts: major determinants of nucleosome organization. Curr. Opin. Struct. Biol. 2009, 19:65-71.
30. Osley M.A., Tsukuda T., Nickoloff J.A. ATP-dependent chromatin remodeling factors and DNA damage repair. Mutat. Res. 2007, 618:65-80.
31. Waters R., Teng Y., Yu Y., Yu S., Reed S.H. Tilting at windmills? The nucleotide excision repair of chromosomal DNA. DNA Repair 2009, 8:146-152.
32. Palomera-Sanchez Z., Zurita M. Open, repair and close again: chromatin dynamics and the response to UV-induced DNA damage. DNA Repair 2011, 10:119-125.
33. Czaja W., Mao P., Smerdon M.J. The emerging roles of ATP-dependent chromatin remodeling enzymes in nucleotide excision repair. Int. J. Mol. Sci. 2012, 13:11954-11973.
34. Lans H., Marteijn J.A., Vermeulen W. ATP-dependent chromatin remodeling in the DNA-damage response. Epigenet. Chromatin 2012, 5:4.
35. Nag R., Smerdon M.J. Altering the chromatin landscape for nucleotide excision repair. Mutat. Res. 2009, 682:13-20.
36. Rhee H.S., Pugh B.F. Comprehensive genome-wide protein-DNA interactions detected at single-nucleotide resolution. Cell 2011, 147:1408-1419.
37. Bryan D.S., Ransom M., Adane B., York K., Hesselberth J.R. High resolution mapping of modified DNA nucleobases using excision repair enzymes. Genome Res. 2014, 24:1534-1542.
38. Krokan H.E., Drablos F., Slupphaug G. Uracil in DNA-occurrence, consequences and repair. Oncogene 2002, 21:8935-8948.
39. Vertessy B.G., Toth J. Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases. Acc. Chem. Res. 2009, 42:97-106.
40. Bowman K.K., Sidik K., Smith C.A., Taylor J.S., Doetsch P.W., Freyer G.A. A new ATP-independent DNA endonuclease from Schizosaccharomyces pombe that recognizes cyclobutane pyrimidine dimers and 6-4 photoproducts. Nucleic Acids Res. 1994, 22:3026-3032.
41. Avery A.M., Kaur B., Taylor J.S., Mello J.A., Essigmann J.M., Doetsch P.W. Substrate specificity of ultraviolet DNA endonuclease (UVDE/Uve1p) from Schizosaccharomyces pombe. Nucleic Acids Res. 1999, 27:2256-2264.
42. Kanno S., Iwai S., Takao M., Yasui A. Repair of apurinic/apyrimidinic sites by UV damage endonuclease; a repair protein for UV and oxidative damage. Nucleic Acids Res. 1999, 27:3096-3103.
43. Williams J.S., Kunkel T.A. Ribonucleotides in DNA: origins, repair and consequences. DNARepair 2014, 19:27-37.
44. Clausen A.R., Lujan S.A., Burkholder A.B., Orebaugh C.D., Williams J.S., Clausen M.F., Malc E.P., Mieczkowski P.A., Fargo D.C., Smith D.J., Kunkel T.A. Tracking replication enzymology in vivo by genome-wide mapping of ribonucleotide incorporation. Nat. Struct. Mol. Biol. 2015, 22:185-191.
45. Daigaku Y., Keszthelyi A., Muller C.A., Miyabe I., Brooks T., Retkute R., Hubank M., Nieduszynski C.A., Carr A.M. A global profile of replicative polymerase usage. Nat. Struct. Mol. Biol. 2015, 22:192-198.
46. Koh K.D., Balachander S., Hesselberth J.R., Storici F. Ribose-seq: global mapping of ribonucleotides embedded in genomic DNA. Nat. Methods 2015, 12:251-257.
47. Reijns M.A., Kemp H., Ding J., de Proce S.M., Jackson A.P., Taylor M.S. Lagging-strand replication shapes the mutational landscape of the genome. Nature 2015, 518:502-506.
48. Nick McElhinny S.A., Kumar D., Clark A.B., Watt D.L., Watts B.E., Lundstrom E.B., Johansson E., Chabes A., Kunkel T.A. Genome instability due to ribonucleotide incorporation into DNA. Nat. Chem. Biol. 2010, 6:774-781.
49. Maga G., Villani G., Tillement V., Stucki M., Locatelli G.A., Frouin I., Spadari S., Hubscher U. Okazaki fragment processing: modulation of the strand displacement activity of DNA polymerase delta by the concerted action of replication protein A, proliferating cell nuclear antigen, and flap endonuclease-1. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14298-14303.
50. Pavlov Y.I., Frahm C., Nick McElhinny S.A., Niimi A., Suzuki M., Kunkel T.A. Evidence that errors made by DNA polymerase alpha are corrected by DNA polymerase delta. Cur. Biol.: CB 2006, 16:202-207.
51. Zheng L., Shen B. Okazaki fragment maturation: nucleases take centre stage. J. Mol. Cell Biol. 2011, 3:23-30.
52. Kunkel T.A. Balancing eukaryotic replication asymmetry with replication fidelity. Curr. Opin. Chem. Biol. 2011, 15:620-626.
53. Warnecke T., Batada N.N., Hurst L.D. The impact of the nucleosome code on protein-coding sequence evolution in yeast. PLoS Genet. 2008, 4:e1000250.
54. Washietl S., Machne R., Goldman N. Evolutionary footprints of nucleosome positions in yeast. Trends Genet.: TIG 2008, 24:583-587.
55. Sasaki S., Mello C.C., Shimada A., Nakatani Y., Hashimoto S., Ogawa M., Matsushima K., Gu S.G., Kasahara M., Ahsan B., Sasaki A., Saito T., Suzuki Y., Sugano S., Kohara Y., Takeda H., Fire A., Morishita S. Chromatin-associated periodicity in genetic variation downstream of transcriptional start sites. Science 2009, 323:401-404.
56. Prendergast J.G., Semple C.A. Widespread signatures of recent selection linked to nucleosome positioning in the human lineage. Genome Res. 2011, 21:1777-1787.
57. Alexandrov L.B., Nik-Zainal S., Wedge D.C., Campbell P.J., Stratton M.R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 2013, 3:246-259.
58. Poon S., McPherson J., Tan P., Teh B., Rozen S. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med. 2014, 6:24.
59. Pfeifer G.P., You Y.H., Besaratinia A. Mutations induced by ultraviolet light. Mutat. Res. 2005, 571:19-31.
60. Sage E. Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem. Photobiol. 1993, 57:163-174.
61. Pfeifer G.P. Formation and processing of UV photoproducts: effects of DNA sequence and chromatin environment. Photochem. Photobiol. 1997, 65:270-283.
62. Johnson R.E., Washington M.T., Prakash S., Prakash L. Fidelity of human DNA polymerase eta. J. Biol. Chem. 2000, 275:7447-7450.
63. Masutani C., Kusumoto R., Iwai S., Hanaoka F. Mechanisms of accurate translesion synthesis by human DNA polymerase eta. EMBO J. 2000, 19:3100-3109.
64. Johnson R.E., Prakash S., Prakash L. Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta. Science 1999, 283:1001-1004.
65. Tu Y., Dammann R., Pfeifer G.P. Sequence and time-dependent deamination of cytosine bases in UVB-induced cyclobutane pyrimidine dimers in vivo. J. Mol. Biol. 1998, 284:297-311.
66. Burger A., Fix D., Liu H., Hays J., Bockrath R. In vivo deamination of cytosine-containing cyclobutane pyrimidine dimers in E. coli: a feasible part of UV-mutagenesis. Mutat. Res. 2003, 522:145-156.
67. Peng W., Shaw B.R. Accelerated deamination of cytosine residues in UV-induced cyclobutane pyrimidine dimers leads to CC→TT transitions. Biochemistry 1996, 35:10172-10181.
68. Pfeifer G.P., Denissenko M.F., Olivier M., Tretyakova N., Hecht S.S., Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002, 21:7435-7451.
69. Yoon J.H., Besaratinia A., Feng Z., Tang M.S., Amin S., Luch A., Pfeifer G.P. DNA damage, repair, and mutation induction by (+)-Syn and (-)-anti-dibenzo[a,l]pyrene-11, 12-diol-13,14-epoxides in mouse cells. Cancer Res. 2004, 64:7321-7328.
70. Pfeifer G.P., Besaratinia A. Mutational spectra of human cancer. Hum. Genet. 2009, 125:493-506.
71. Berger M.F., Hodis E., Heffernan T.P., Deribe Y.L., Lawrence M.S., Protopopov A., Ivanova E., Watson I.R., Nickerson E., Ghosh P., Zhang H., Zeid R., Ren X., Cibulskis K., Sivachenko A.Y., Wagle N., Sucker A., Sougnez C., Onofrio R., Ambrogio L., Auclair D., Fennell T., Carter S.L., Drier Y., Stojanov P., Singer M.A., Voet D., Jing R., Saksena G., Barretina J., Ramos A.H., Pugh T.J., Stransky N., Parkin M., Winckler W., Mahan S., Ardlie K., Baldwin J., Wargo J., Schadendorf D., Meyerson M., Gabriel S.B., Golub T.R., Wagner S.N., Lander E.S., Getz G., Chin L., Garraway L.A. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 2012, 485:502-506.
72. Furney S.J., Turajlic S., Stamp G., Nohadani M., Carlisle A., Thomas J.M., Hayes A., Strauss D., Gore M., van den Oord J., Larkin J., Marais R. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J. Pathol. 2013, 230:261-269.
73. Furney S.J., Turajlic S., Stamp G., Thomas J.M., Hayes A., Strauss D., Gavrielides M., Xing W., Gore M., Larkin J., Marais R. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigm. Cell Melanoma Res. 2014, 27:835-838.
74. Gartner J.J., Davis S., Wei X., Lin J.C., Trivedi N.S., Teer J.K., Program N.C.S., Meltzer P.S., Rosenberg S.A., Samuels Y. Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma. BMC Genomics 2012, 13:505.
75. Gartner J.J., Parker S.C., Prickett T.D., Dutton-Regester K., Stitzel M.L., Lin J.C., Davis S., Simhadri V.L., Jha S., Katagiri N., Gotea V., Teer J.K., Wei X., Morken M.A., Bhanot U.K., Program N.C.S., Chen G., Elnitski L.L., Davies M.A., Gershenwald J.E., Carter H., Karchin R., Robinson W., Robinson S., Rosenberg S.A., Collins F.S., Parmigiani G., Komar A.A., Kimchi-Sarfaty C., Hayward N.K., Margulies E.H., Samuels Y. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:13481-13486.
76. Krauthammer M., Kong Y., Ha B.H., Evans P., Bacchiocchi A., McCusker J.P., Cheng E., Davis M.J., Goh G., Choi M., Ariyan S., Narayan D., Dutton-Regester K., Capatana A., Holman E.C., Bosenberg M., Sznol M., Kluger H.M., Brash D.E., Stern D.F., Materin M.A., Lo R.S., Mane S., Ma S., Kidd K.K., Hayward N.K., Lifton R.P., Schlessinger J., Boggon T.J., Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet. 2012, 44:1006-1014.
77. Kunz M., Dannemann M., Kelso J. High-throughput sequencing of the melanoma genome. Exp. Dermatol. 2013, 22:10-17.
78. Martin M., Masshofer L., Temming P., Rahmann S., Metz C., Bornfeld N., van de Nes J., Klein-Hitpass L., Hinnebusch A.G., Horsthemke B., Lohmann D.R., Zeschnigk M. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat. Genet. 2013, 45:933-936.
79. Nikolaev S.I., Rimoldi D., Iseli C., Valsesia A., Robyr D., Gehrig C., Harshman K., Guipponi M., Bukach O., Zoete V., Michielin O., Muehlethaler K., Speiser D., Beckmann J.S., Xenarios I., Halazonetis T.D., Jongeneel C.V., Stevenson B.J., Antonarakis S.E. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat. Genet. 2012, 44:133-139.
80. Stark M.S., Woods S.L., Gartside M.G., Bonazzi V.F., Dutton-Regester K., Aoude L.G., Chow D., Sereduk C., Niemi N.M., Tang N., Ellis J.J., Reid J., Zismann V., Tyagi S., Muzny D., Newsham I., Wu Y., Palmer J.M., Pollak T., Youngkin D., Brooks B.R., Lanagan C., Schmidt C.W., Kobe B., MacKeigan J.P., Yin H., Brown K.M., Gibbs R., Trent J., Hayward N.K. Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nat. Genet. 2012, 44:165-169.
81. Wei X., Walia V., Lin J.C., Teer J.K., Prickett T.D., Gartner J., Davis S., Program N.C.S., Stemke-Hale K., Davies M.A., Gershenwald J.E., Robinson W., Robinson S., Rosenberg S.A., Samuels Y. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat. Genet. 2011, 43:442-446.
82. Lawrence M.S., Stojanov P., Polak P., Kryukov G.V., Cibulskis K., Sivachenko A., Carter S.L., Stewart C., Mermel C.H., Roberts S.A., Kiezun A., Hammerman P.S., McKenna A., Drier Y., Zou L., Ramos A.H., Pugh T.J., Stransky N., Helman E., Kim J., Sougnez C., Ambrogio L., Nickerson E., Shefler E., Cortes M.L., Auclair D., Saksena G., Voet D., Noble M., DiCara D., Lin P., Lichtenstein L., Heiman D.I., Fennell T., Imielinski M., Hernandez B., Hodis E., Baca S., Dulak A.M., Lohr J., Landau D.A., Wu C.J., Melendez-Zajgla J., Hidalgo-Miranda A., Koren A., McCarroll S.A., Mora J., Lee R.S., Crompton B., Onofrio R., Parkin M., Winckler W., Ardlie K., Gabriel S.B., Roberts C.W., Biegel J.A., Stegmaier K., Bass A.J., Garraway L.A., Meyerson M., Golub T.R., Gordenin D.A., Sunyaev S., Lander E.S., Getz G. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013, 499:214-218.
83. Alexandrov L.B., Nik-Zainal S., Wedge D.C., Aparicio S.A., Behjati S., Biankin A.V., Bignell G.R., Bolli N., Borg A., Borresen-Dale A.L., Boyault S., Burkhardt B., Butler A.P., Caldas C., Davies H.R., Desmedt C., Eils R., Eyfjord J.E., Foekens J.A., Greaves M., Hosoda F., Hutter B., Ilicic T., Imbeaud S., Imielinsk M., Jager N., Jones D.T., Jones D., Knappskog S., Kool M., Lakhani S.R., Lopez-Otin C., Martin S., Munshi N.C., Nakamura H., Northcott P.A., Pajic M., Papaemmanuil E., Paradiso A., Pearson J.V., Puente X.S., Raine K., Ramakrishna M., Richardson A.L., Richter J., Rosenstiel P., Schlesner M., Schumacher T.N., Span P.N., Teague J.W., Totoki Y., Tutt A.N., Valdes-Mas R., van Buuren M.M., van't Veer L., Vincent-Salomon A., Waddell N., Yates L.R., Zucman-Rossi J., Futreal P.A., McDermott U., Lichter P., Meyerson M., Grimmond S.M., Siebert R., Campo E., Shibata T., Pfister S.M., Campbell P.J., Stratton M.R. Signatures of mutational processes in human cancer. Nature 2013, 500:415-421.
84. Govindan R., Ding L., Griffith M., Subramanian J., Dees N.D., Kanchi K.L., Maher C.A., Fulton R., Fulton L., Wallis J., Chen K., Walker J., McDonald S., Bose R., Ornitz D., Xiong D., You M., Dooling D.J., Watson M., Mardis E.R., Wilson R.K. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012, 150:1121-1134.
85. Lee W., Jiang Z., Liu J., Haverty P.M., Guan Y., Stinson J., Yue P., Zhang Y., Pant K.P., Bhatt D., Ha C., Johnson S., Kennemer M.I., Mohan S., Nazarenko I., Watanabe C., Sparks A.B., Shames D.S., Gentleman R., de Sauvage F.J., Stern H., Pandita A., Ballinger D.G., Drmanac R., Modrusan Z., Seshagiri S., Zhang Z. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010, 465:473-477.
86. Pleasance E.D., Stephens P.J., O'Meara S., McBride D.J., Meynert A., Jones D., Lin M.L., Beare D., Lau K.W., Greenman C., Varela I., Nik-Zainal S., Davies H.R., Ordonez G.R., Mudie L.J., Latimer C., Edkins S., Stebbings L., Chen L., Jia M., Leroy C., Marshall J., Menzies A., Butler A., Teague J.W., Mangion J., Sun Y.A., McLaughlin S.F., Peckham H.E., Tsung E.F., Costa G.L., Lee C.C., Minna J.D., Gazdar A., Birney E., Rhodes M.D., McKernan K.J., Stratton M.R., Futreal P.A., Campbell P.J. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010, 463:184-190.
87. Bass A.J., Watanabe H., Mermel C.H., Yu S., Perner S., Verhaak R.G., Kim S.Y., Wardwell L., Tamayo P., Gat-Viks I., Ramos A.H., Woo M.S., Weir B.A., Getz G., Beroukhim R., O'Kelly M., Dutt A., Rozenblatt-Rosen O., Dziunycz P., Komisarof J., Chirieac L.R., Lafargue C.J., Scheble V., Wilbertz T., Ma C., Rao S., Nakagawa H., Stairs D.B., Lin L., Giordano T.J., Wagner P., Minna J.D., Gazdar A.F., Zhu C.Q., Brose M.S., Cecconello I., UR, Marie S.K., Dahl O., Shivdasani R.A., Tsao M.S., Rubin M.A., Wong K.K., Regev A., Hahn W.C., Beer D.G., Rustgi A.K., Meyerson M. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet. 2009, 41:1238-1242.
88. Imielinski M., Berger A.H., Hammerman P.S., Hernandez B., Pugh T.J., Hodis E., Cho J., Suh J., Capelletti M., Sivachenko A., Sougnez C., Auclair D., Lawrence M.S., Stojanov P., Cibulskis K., Choi K., de Waal L., Sharifnia T., Brooks A., Greulich H., Banerji S., Zander T., Seidel D., Leenders F., Ansen S., Ludwig C., Engel-Riedel W., Stoelben E., Wolf J., Goparju C., Thompson K., Winckler W., Kwiatkowski D., Johnson B.E., Janne P.A., Miller V.A., Pao W., Travis W.D., Pass H.I., Gabriel S.B., Lander E.S., Thomas R.K., Garraway L.A., Getz G., Meyerson M. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012, 150:1107-1120.
89. Roberts S.A., Lawrence M.S., Klimczak L.J., Grimm S.A., Fargo D., Stojanov P., Kiezun A., Kryukov G.V., Carter S.L., Saksena G., Harris S., Shah R.R., Resnick M.A., Getz G., Gordenin D.A. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 2013, 45:970-976.
90. Burns M.B., Temiz N.A., Harris R.S. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. 2013, 45:977-983.
91. Bacolla A., Temiz N.A., Yi M., Ivanic J., Cer R.Z., Donohue D.E., Ball E.V., Mudunuri U.S., Wang G., Jain A., Volfovsky N., Luke B.T., Stephens R.M., Cooper D.N., Collins J.R., Vasquez K.M. Guanine holes are prominent targets for mutation in cancer and inherited disease. PLoS Genet. 2013, 9:e1003816.
92. Hoang M.L., Chen C.H., Sidorenko V.S., He J., Dickman K.G., Yun B.H., Moriya M., Niknafs N., Douville C., Karchin R., Turesky R.J., Pu Y.S., Vogelstein B., Papadopoulos N., Grollman A.P., Kinzler K.W., Rosenquist T.A. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci. Transl. Med. 2013, 5:197ra102.
93. Hollstein M., Moriya M., Grollman A.P., Olivier M. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid. Mutat. Res. 2013, 753:41-49.
94. Poon S.L., Pang S.T., McPherson J.R., Yu W., Huang K.K., Guan P., Weng W.H., Siew E.Y., Liu Y., Heng H.L., Chong S.C., Gan A., Tay S.T., Lim W.K., Cutcutache I., Huang D., Ler L.D., Nairismagi M.L., Lee M.H., Chang Y.H., Yu K.J., Chan-On W., Li B.K., Yuan Y.F., Qian C.N., Ng K.F., Wu C.F., Hsu C.L., Bunte R.M., Stratton M.R., Futreal P.A., Sung W.K., Chuang C.K., Ong C.K., Rozen S.G., Tan P., Teh B.T. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci. Transl. Med. 2013, 5:197ra101.
95. Stirling P.C., Shen Y., Corbett R., Jones S.J., Hieter P. Genome destabilizing mutator alleles drive specific mutational trajectories in Saccharomyces cerevisiae. Genetics 2014, 196:403-412.
96. Meier B., Cooke S.L., Weiss J., Bailly A.P., Alexandrov L.B., Marshall J., Raine K., Maddison M., Anderson E., Stratton M.R., Gartner A., Campbell P.J. C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency. Genome Res. 2014, 24:1624-1636.
97. Serero A., Jubin C., Loeillet S., Legoix-Ne P., Nicolas A.G. Mutational landscape of yeast mutator strains. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:1897-1902.
98. Parkhomchuk D., Amstislavskiy V., Soldatov A., Ogryzko V. Use of high throughput sequencing to observe genome dynamics at a single cell level. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20830-20835.
99. Roberts S.A., Sterling J., Thompson C., Harris S., Mav D., Shah R., Klimczak L.J., Kryukov G.V., Malc E., Mieczkowski P.A., Resnick M.A., Gordenin D.A. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 2012, 46:424-435.
100. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group, The New England journal of medicine, 319 (1988) 1681-1692.
101. Nik-Zainal S., Alexandrov L.B., Wedge D.C., Van Loo P., Greenman C.D., Raine K., Jones D., Hinton J., Marshall J., Stebbings L.A., Menzies A., Martin S., Leung K., Chen L., Leroy C., Ramakrishna M., Rance R., Lau K.W., Mudie L.J., Varela I., McBride D.J., Bignell G.R., Cooke S.L., Shlien A., Gamble J., Whitmore I., Maddison M., Tarpey P.S., Davies H.R., Papaemmanuil E., Stephens P.J., McLaren S., Butler A.P., Teague J.W., Jonsson G., Garber J.E., Silver D., Miron P., Fatima A., Boyault S., Langerod A., Tutt A., Martens J.W., Aparicio S.A., Borg A., Salomon A.V., Thomas G., Borresen-Dale A.L., Richardson A.L., Neuberger M.S., Futreal P.A., Campbell P.J., Stratton M.R. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993.
102. Taylor B.J., Nik-Zainal S., Wu Y.L., Stebbings L.A., Raine K., Campbell P.J., Rada C., Stratton M.R., Neuberger M.S. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2013, 2:e00534.
103. Lada A.G., Dhar A., Boissy R.J., Hirano M., Rubel A.A., Rogozin I.B., Pavlov Y.I. AID/APOBEC cytosine deaminase induces genome-wide kataegis. Biol. Direct 2012, 7:47. discussion 47.
104. Hodgkinson A., Chen Y., Eyre-Walker A. The large-scale distribution of somatic mutations in cancer genomes. Hum. Mutat. 2012, 33:136-143.
105. Stamatoyannopoulos J.A., Adzhubei I., Thurman R.E., Kryukov G.V., Mirkin S.M., Sunyaev S.R. Human mutation rate associated with DNA replication timing. Nat. Genet. 2009, 41:393-395.
106. Woo Y.H., Li W.H. DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. Nat. Commun. 2012, 3:1004.
107. Koren A., Polak P., Nemesh J., Michaelson J.J., Sebat J., Sunyaev S.R., McCarroll S.A. Differential relationship of DNA replication timing to different forms of human mutation and variation. Am. J. Hum. Genet. 2012, 91:1033-1040.
108. Schuster-Bockler B., Lehner B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 2012, 488:504-507.
109. Liu L., De S., Michor F. DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes. Nat. Commun. 2013, 4:1502.
110. Polak P., Lawrence M.S., Haugen E., Stoletzki N., Stojanov P., Thurman R.E., Garraway L.A., Mirkin S., Getz G., Stamatoyannopoulos J.A., Sunyaev S.R. Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair. Nat. Biotechnol. 2014, 32:71-75.
111. Zheng C.L., Wang N.J., Chung J., Moslehi H., Sanborn J.Z., Hur J.S., Collisson E.A., Vemula S.S., Naujokas A., Chiotti K.E., Cheng J.B., Fassihi H., Blumberg A.J., Bailey C.V., Fudem G.M., Mihm F.G., Cunningham B.B., Neuhaus I.M., Liao W., Oh D.H., Cleaver J.E., LeBoit P.E., Costello J.F., Lehmann A.R., Gray J.W., Spellman P.T., Arron S.T., Huh N., Purdom E., Cho R.J. Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes. Cell Rep. 2014, 9:1228-1234.